Harris Erik
Ultragenyx Pharmaceutical Inc · EVP & Chief Commercial Officer
Harris Erik is listed in public filings as officer: EVP & Chief Commercial Officer. This Harris Erik insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Ultragenyx Pharmaceutical Inc (RARE), Rezolute, Inc. (RZLT), and Inozyme Pharma, Inc. (INZY). Investors use Harris Erik's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $1.2M50k shares | Grant / ExerciseApr 16, 2026 | $1.2M50k shares | $24.52 | -- | |
| --118.4k shares | Grant / ExerciseApr 16, 2026 | Disclosure amount unavailable28.9k shares | -- | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $2.0M89.5k shares | SellMar 2, 2026 | $240.3K10.5k shares | $22.80 | -- | |
| --99.5k shares | Grant / ExerciseMar 1, 2026 | Disclosure amount unavailable11.6k shares | -- | -- | |
| --21k shares | Grant / ExerciseNov 19, 2025 | Disclosure amount unavailable21k shares | -- | -- | |
| $122k12k shares | Grant / ExerciseNov 19, 2025 | $121.9K12k shares | $10.16 | -- | |
| $173k60k shares | Grant / ExerciseMar 25, 2025 | $173.4K60k shares | $2.89 | -- | |
| $3.7M87.9k shares | SellMar 3, 2025 | $635.8K15.1k shares | $42.10 | -- | |
| $1.3M30.2k shares | Grant / ExerciseMar 1, 2025 | $1.3M30.2k shares | $42.92 | -- | |
| --84k shares | Grant / ExerciseMar 1, 2025 | Disclosure amount unavailable16.8k shares | -- | -- | |
| --102.4k shares | Grant / ExerciseMar 1, 2025 | Disclosure amount unavailable18.4k shares | -- | -- | |
| $283k56k shares | Grant / ExerciseOct 3, 2024 | $283.4K56k shares | $5.06 | -- |